RadNet Acquires Gleamer for Up to €230M, Targets $30M ARR in 2026
RadNet will acquire Gleamer SAS for up to €230 million, integrating it into DeepHealth to form the largest global radiology AI provider. Gleamer’s ARR soared over 90% annually to an expected $30 million in 2026, and integration targets AI workflow efficiencies by Q3 2026.
1. Transaction Overview
RadNet has agreed to acquire Paris-based Gleamer SAS in an all-cash deal valued at up to €230 million, including post-closing milestones. The transaction will fold Gleamer into DeepHealth, RadNet’s wholly owned subsidiary, positioning the combined entity as the world’s largest provider of radiology clinical AI solutions.
2. Gleamer Growth Metrics and Portfolio
Gleamer serves over 700 customer contracts across 44 countries with a cloud-first, FDA-cleared and CE-marked portfolio covering musculoskeletal, breast, lung and neurologic imaging. Its team of 130 professionals achieved an ARR CAGR of over 90% from 2022 to 2025, and ARR is projected to reach approximately $30 million in 2026.
3. Strategic Rationale and Integration Plan
The acquisition augments DeepHealth’s global commercial and R&D teams, combining native AI solutions across MR, CT, X-ray, mammography and ultrasound modalities. Integration will focus on automated exam triage and draft reporting capabilities to enhance diagnostic accuracy and standardization.
4. Expected Synergies and Operational Impact
Deploying Gleamer’s AI-driven workflows across RadNet’s imaging network—where X-ray accounts for nearly 25% of volume—is expected to yield measurable productivity gains. RadNet aims to implement end-to-end AI-enabled processes, driving cost efficiencies and improved patient care by the third quarter of 2026.